Key Takeaways
• People with higher omega-3 intake have ~20% lower risk of dementia in large observational studies.
• Your brain is ~60% fat, and DHA is its most important structural fat.
• EPA has significant anti-inflammatory effects on microglial cells (brain’s immune cells) and helps with neuroinflammation.
• APOE e4 is a gene that is associated with a 3–5x higher risk of Alzheimer’s disease. Supplementing with Omega-3 prior at the onset of signs of dementia has minimal benefit than supplementing prior to dementia.
• The Omega-3 Index provides insight into your cognitive risk. An index below 5% is associated with increased risk of cognitive decline.
Want to understand the science? Keep reading below 👇
So What Do Omega-3s Do for Your Brain?
DHA is the most abundant Omega-3 fatty accident in the brain and concentrated in the membranes of neurons. It may have multiple impacts including membrane function, improving synaptic function (how nerves communicate), and reducing inflammation. Compared to DHA, EPA is level in the brain are 100x lower levels. However, EPA is a potent anti-inflammatory effects on microglial cells, which are the brain’s immune cells.
What Do Clinical Trials Actually Show?
Here’s where it gets more nuanced. The major randomized controlled trials in healthy older adults have generally not found that omega-3 supplements improve cognition while observational studies demonstrated benefit.
📋 What the Clinical Trials Found
VITAL-Cog (n=3,424): No cognitive benefit from 840 mg EPA+DHA/day over 2–3 years in healthy older adults.
MAPT trial (n=1,680): No significant improvement from 800 mg DHA + 225 mg EPA over 3 years in adults with memory complaints. Post-hoc analysis showed that the following groups did benefit within the study: patients with low Omega-3 index (<5%) or positive amyloid status.
2016 Cochrane Review analyzed three high quality RCTs* involving 632 patients with mild to moderate Alzheimer’s disease and found no evidence of benefit from Omega-3 supplementation on cognitive function. It concluded that once dementia is established, omega-3 supplementation does not alter disease course.
Meanwhile in observational studies including the ADNI Cohort, UK biobank Fish oil supplementation study, and meta-analysis published in 2016 and 2023 have demonstrated incremental increases in DHA were associated with decrease risk in dementia risk and cognitive decline.
Why the Gap Between Trials and Observational Studies?
Most trials use low doses (~1 g/day) for only 2–3 years.
The real benefit may reflect decades of adequate omega-3 status instead of a short supplement course.
Omega-3s likely work best as prevention, started early. It is not a treatment once decline begins.
Baseline omega-3 status is critical — multiple trials show benefits only in participants with low omega-3 index at baseline, not in those with adequate levels
APOE Genetics: Who Benefits Most?
APOE e4 gene can be identified by a simple genetic blood test. It increases risk of dementia by promoting early amyloid-Beta accumulation. Carriers face a 3–5x higher risk of Alzheimer’s disease and metabolize DHA faster than non-carriers, meaning their brains may be chronically deficient in DHA even on a normal diet.
What APOE e4 Means for Omega-3s
• APOE e4 carriers break down DHA faster, so their brains may be deficient even at normal dietary intake.
• A 10-year study (ADNI cohort) found that long-term omega-3 use protected cognition and lowered amyloid burden in APOE e4 carriers, but not in non-carriers.
• Once dementia is established, the benefit disappears regardless of genotype. The window to supplement is pre-dementia.
If you carry APOE e4, starting supplementation in your 40s or 50s is likely far more impactful than waiting for symptoms.
What Should You Actually Do?
Omega-3 supplementing is one leg of the stool. A multi domain approach is as important and how you live your life and optimize your health is equally important. The following are recommendations to keep risk low:
30 minutes/day, 5 days/week of moderate intensity activity
Cognitive training and social engagement
Avoiding processed food to minimize metabolic and vascular risk factors
Optimizing blood pressure and lipid profile
7-8 hours quality of sleep, including stage 4 sleep.
Your Situation | What to Do |
Omega-3 Index below 5% | Supplementing with 1,000–2,000 mg EPA+DHA daily can reduce your risk of cognitive decline. Retest in 3 months to confirm levels are rising. |
APOE e4 carrier | Starting supplementation early and check Omega-3 status. |
✅ The Bottom Line
• Omega-3s are not a universal brain supplement, but for the right people and started at the right time, the evidence is compelling.
• People with an Omega-3 Index below 5%, APOE e4 carriers, or those with early memory concerns have the clearest case for supplementation.
• The goal is to build adequate omega-3 status before mental decline begins.
Target: Omega-3 Index above 8%, with at least 1,000–2,000 mg EPA+DHA daily if your levels are low.
References
Wei et al., Am J Clin Nutr 2023 | von Schacky, Nutrients 2021 | Zhang et al., Prog Lipid Res 2024 | Ebright et al., Trends Endocrinol Metab 2024 | Li et al., Eur J Neurol 2022 | Rouch et al., Am J Clin Nutr 2022 | Gebauer et al., Am J Clin Nutr 2006 | Shahinfar et al., Sci Rep 2025 | Coley et al., J Nutr Health Aging 2018 | Welty et al., Arterioscler Thromb Vasc Biol 2024 | Morris et al., JAMA 2016 | Calder et al., Nutr Res Rev 2025 | Scarmeas et al., Lancet Neurol 2018 | Lewis et al., Nutr Res Rev 2025